Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Novel Oral Anticoagulants”

72 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 72 results

Post-approval studies (Phase 4)Looking for participantsNCT04436978
What this trial is testing

What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?

Who this might be right for
Acute Coronary SyndromeMyocardial InfarctionAtrial Fibrillation+8 more
St. Antonius Hospital 2,000
Not applicableUnknownNCT01588119
What this trial is testing

Register for New Oral Anticoagulants

Who this might be right for
Anticoagulation Treatment
GWT-TUD GmbH 5,000
Large-scale testing (Phase 3)Looking for participantsNCT04066764
What this trial is testing

Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters

Who this might be right for
Venous Thromboembolism
Second Affiliated Hospital, School of Medicine, Zhejiang University 200
Not applicableStudy completedNCT03182218
What this trial is testing

Periprocedural Direct Oral Anticoagulant Management

Who this might be right for
Periprocedural Complication
Fundación para la Investigación del Hospital Clínico de Valencia 1,100
Not applicableUnknownNCT02623049
What this trial is testing

Direct Oral Anticoagulants Pharmacodynamics in Octogenarian Patients With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation and Flutter
Rabin Medical Center 150
Post-approval studies (Phase 4)UnknownNCT01478282
What this trial is testing

Reversal of the Antithrombotic Action of New Oral Anticoagulants

Who this might be right for
ThrombosisAnticoagulant-induced BleedingAnticoagulant Overdosage+1 more
Gines Escolar 10
Not applicableStudy completedNCT02344901
What this trial is testing

ReAl-life Multicentre Survey Evaluating Stroke Prevention Strategies (RAMSES)

Who this might be right for
Thrombotic StrokeAtrial Fibrillation and Flutter
Muğla Sıtkı Koçman University 6,273
Large-scale testing (Phase 3)Study completedNCT03996772
What this trial is testing

PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation

Who this might be right for
Atrial FibrillationIntracerebral Hemorrhage
Imperial College London 319
Not applicableNot Yet RecruitingNCT05764356
What this trial is testing

Imapct of bioMarkers on Pharmacodynamics and Bleeding Risk of Direct Oral AntiCoagulants and Ticagrelor Study II

Who this might be right for
Novel Oral AnticoagulantsNOACsRivaroxaban+9 more
Peking University First Hospital 2,000
Not applicableUnknownNCT04942873
What this trial is testing

The Adherence to Oral Anticoagulant in Chinese Patients With NVAF

Who this might be right for
Nonvalvular Atrial Fibrillation
Second Affiliated Hospital, School of Medicine, Zhejiang University 500
Not applicableStudy completedNCT01850797
What this trial is testing

Registry of Acute Stroke Under New Oral Anticoagulants -Pilot (RASUNOA-Pilot)

Who this might be right for
Ischemic StrokeIntracranial Hemorrhage
University Hospital Heidelberg 353
Not applicableUnknownNCT03161496
What this trial is testing

Impact of Biomarkers on Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants

Who this might be right for
Novel Oral AnticoagulantsNOACsRivaroxaban+6 more
Cui Yimin 1,200
Large-scale testing (Phase 3)UnknownNCT01923818
What this trial is testing

Treatment of Rivaroxaban Versus Aspirin for Non-disabling Cerebrovascular Events

Who this might be right for
Ischemic StrokeTIA
Xijing Hospital 3,700
Not applicableUnknownNCT02906527
What this trial is testing

Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 75 Years and Over Suffering From Non Valvular Atrial Fibrillation (nv AF)

Who this might be right for
Non Valvular Atrial Fibrillation (nv AF)
Assistance Publique - Hôpitaux de Paris 150,000
Not applicableStudy completedNCT02185027
What this trial is testing

Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants

Who this might be right for
Venous ThromboembolismAtrial Fibrillation
University Hospital, Grenoble 1,166
Large-scale testing (Phase 3)UnknownNCT03570281
What this trial is testing

Edoxaban for the Treatment of Coagulopathy in Patients With Active Cancer and Acute Ischemic Stroke: a Pilot Study. (ENCHASE Study)

Who this might be right for
Correction of Cancer-related Coagulopathy With Novel Oral Anticoagulant (Edoxaban)
Samsung Medical Center 40
Testing effectiveness (Phase 2)Study completedNCT00074828
What this trial is testing

New Oral Anticoagulant Therapy for the Prevention of Blood Clots Following Hip or Knee Replacement Surgery

Who this might be right for
Total Knee ReplacementTotal Hip Replacement
Eli Lilly and Company 511
Not applicableStudy completedNCT06220422
What this trial is testing

Assessment of a Procedure for Managing Oral Anticoagulants (NACO) in the Management of Fractures

Who this might be right for
Femur Fracture
Hôpital NOVO 127
Not applicableStudy completedNCT03292666
What this trial is testing

Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism Study

Who this might be right for
Venous ThromboembolismAnticoagulants and Bleeding Disorders
University of California, San Francisco 39,603
Not applicableUnknownNCT02354456
What this trial is testing

Atrial Fibrillation in Turkey: Epidemiologic Registry-2

Who this might be right for
Atrial Fibrillation
Dicle University 4,100
Load More Results